Skip to main content
Charles Argoff, MD, Neurology, Albany, NY

CharlesArgoffMD

Neurology Albany, NY

Pain Medicine

Professor of Neurology at Albany Medical College. Director of the Comprehensive Pain Center at Albany Medical Center.

Dr. Argoff is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Argoff's full profile

Already have an account?

  • Office

    47 New Scotland Ave
    Albany, NY 12208
    Phone+1 518-262-5226

Education & Training

  • Stony Brook Medicine/University Hospital
    Stony Brook Medicine/University HospitalResidency, Neurology, 1985 - 1988
  • Stony Brook Medicine/University Hospital
    Stony Brook Medicine/University HospitalInternship, Internal Medicine, 1984 - 1985
  • Northwestern University The Feinberg School of Medicine
    Northwestern University The Feinberg School of MedicineClass of 1984

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1986 - 2027
  • MD State Medical License
    MD State Medical License 1988 - 1990
  • Neurology
    American Board of Psychiatry and Neurology Neurology
  • Pain Medicine
    American Board of Psychiatry and Neurology Pain Medicine

Awards, Honors, & Recognition

  • 518 Life Magazine Castle Connolly, 2014
  • America's Top Doctors Castle Connolly, 2012-2014
  • Hudson Valley Magazine Castle Connolly, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Opioids vs Nonopioids for Chronic Back, Hip, or Knee Pain  
    Edward Covington, Charles Argoff, Steven P Stanos, JAMA

Press Mentions

  • FDA Approves First New Non-Opioid Pain Pill in Decades
    FDA Approves First New Non-Opioid Pain Pill in DecadesJanuary 31st, 2025
  • FDA Approves Painkiller Designed to Eliminate the Risk of Addiction Associated with Opioids
    FDA Approves Painkiller Designed to Eliminate the Risk of Addiction Associated with OpioidsJanuary 31st, 2025
  • FDA Approves New Painkiller That Shows Promise and Challenges of Opioid Alternatives
    FDA Approves New Painkiller That Shows Promise and Challenges of Opioid AlternativesJanuary 30th, 2025
  • Join now to see all

Professional Memberships